5 completed. 5 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 4 | Completed 4 |
Follow Long COVID: new trials by email Literature Review of Long COVID trials Research Report on Long COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of LAU-7b for the Treatment of Long COVID in Adults LAU-7b for 3 cycles, LAU-7b for 1 cycle, then placebo, Placebo for 3 cycles - Long COVID | Phase 2 / Phase 3 | Completed | Laurent Pharmaceuticals Inc. | 272 | 2023-11-15 | 2026-01-06 |
| Pycnogenol® in Post-COVID-19 Condition Pycnogenol®, Placebo - Post COVID-19 Condition, Long COVID | Phase 3 | Completed | University of Zurich | 153 | 2023-06-07 | 2026-04-29 |
| RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Ibudilast, Pentoxifylline, Placebo - Long COVID, Post COVID Condition | Phase 2 / Phase 3 | Completed | University Health Network, Toronto | 460 | 2023-05-31 | 2026-02-23 |
| Fluvoxamine for Long COVID-19 Fluvoxamine - Long COVID | Phase 2 / Phase 3 | Completed | Washington University School of Medicine | 191 | 2023-05-15 | 2026-10-07 |
| Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. sodium pyruvate nasal spray - Long COVID | Phase 2 / Phase 3 | Completed | Cellular Sciences, inc. | 22 | 2021-04-27 | 2022-03-09 |
Post-Acute COVID-19 Syndrome (5) · COVID-19 (3)
Chronic Disease (5) · Coronaviridae Infections (5) · Coronavirus Infections (5) · Disease Attributes (5) · Infections (5) · Lung Diseases (5) · Nidovirales Infections (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Pneumonia (5) · Pneumonia, Viral (5) · Post-Infectious Disorders (5) · RNA Virus Infections (5) · Respiratory Tract Diseases (5) · Respiratory Tract Infections (5)
Fenretinide (1) · Fluvoxamine (1) · Pentoxifylline (1) · Sugars (1) · ibudilast (1) · pycnogenols (1)
Cellular Sciences, inc. (1) · Laurent Pharmaceuticals Inc. (1) · University Health Network, Toronto (1) · University of Zurich (1) · Washington University School of Medicine (1)
Canada (2) · United States (2) · Switzerland (1)
Alexia Anagnostopoulos, MD (1) · Angela M Cheung, MD,PhD (1) · Eric Lenze, MD (1) · George Tomlinson, PhD (1) · Jahn S Fehr, Prof., MD (1) · Jean-Marie Houle, PhD (1) · Peter Juni, MD, PhD (1) · Ronald Amen, PhD (1)